• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[中药治疗慢性特发性血小板减少性紫癜的临床评价]

[Clinical evaluation of traditional Chinese medicine for chronic idiopathic thrombocytopenic purpura].

作者信息

Nakayama S, Matsushita A, Ichiba S, Yabe H, Nagai K

机构信息

Department of Immunohematology, Kobe City General Hospital.

出版信息

Rinsho Ketsueki. 1992 Feb;33(2):157-61.

PMID:1635162
Abstract

The efficacy of traditional Chinese medicine (Kampo medicine) was examined in 40 patients with steroid-unresponsive idiopathic thrombocytopenic purpura (ITP). All patients were, at first, given Hochuekihi-to, and when they were refractory, therapy was switched to Sairei-to, Ninjinyoei-to, and Kamikihi-to. The efficacy rate was 20.0% by Hochuekihi-to, 20.7% by Sairei-to, 5.5% by Ninjinyoei-to and 6.7% by Kamikihi-to, respectively. Thus, overall responders were 12 in 40 patients with an effective rate of 30.0%. The mechanism of action of traditional Chinese medicine is discussed in relation to the production of various kinds of cytokines.

摘要

对40例激素无反应性特发性血小板减少性紫癜(ITP)患者的中药(汉方医学)疗效进行了研究。所有患者起初均给予补中益气汤,若出现难治性情况,则将治疗换为柴苓汤、人参养荣汤和加味归脾汤。补中益气汤的有效率为20.0%,柴苓汤为20.7%,人参养荣汤为5.5%,加味归脾汤为6.7%。因此,40例患者中有12例总体有效,有效率为30.0%。结合各种细胞因子的产生对中药的作用机制进行了讨论。

相似文献

1
[Clinical evaluation of traditional Chinese medicine for chronic idiopathic thrombocytopenic purpura].[中药治疗慢性特发性血小板减少性紫癜的临床评价]
Rinsho Ketsueki. 1992 Feb;33(2):157-61.
2
Retrospective analysis of 472 Chinese children with chronic idiopathic thrombocytopenic purpura: a single center experience.472例中国儿童慢性特发性血小板减少性紫癜的回顾性分析:单中心经验
Haematologica. 2005 Jun;90(6):860-1.
3
[A case of Evans's syndrome in which thrombocytopenia and hemolysis was improved by Sairei-to].柴苓汤改善血小板减少症和溶血的Evans综合征1例
Rinsho Ketsueki. 1995 Oct;36(10):1237-9.
4
Alternative therapy for persistent childhood immune thrombocytopenic purpura unresponsive to intravenous immunoglobulin.对于静脉注射免疫球蛋白治疗无效的持续性儿童免疫性血小板减少性紫癜的替代治疗。
Complement Ther Med. 2013 Oct;21(5):525-8. doi: 10.1016/j.ctim.2013.08.005. Epub 2013 Aug 19.
5
Dapsone for chronic idiopathic thrombocytopenic purpura in children and adults--a report on 90 patients.氨苯砜治疗儿童和成人慢性特发性血小板减少性紫癜——90例患者的报告
Eur J Haematol. 2005 Oct;75(4):328-31. doi: 10.1111/j.1600-0609.2005.00545.x.
6
Treatment of idiopathic thrombocytopenic purpura based on TCM syndrome differentiation.基于中医辨证论治的特发性血小板减少性紫癜的治疗
J Tradit Chin Med. 1995 Jun;15(2):83-6.
7
Chronic idiopathic thrombocytopenic purpura in adult Chinese patients: a retrospective single-centered analysis of 1791 cases.成年中国患者慢性特发性血小板减少性紫癜:1791例回顾性单中心分析
Chin Med J (Engl). 2005 Jan 5;118(1):34-7.
8
[Combination chemotherapy (CVP) in a patient with refractory idiopathic thrombocytopenic purpura (ITP)].[难治性特发性血小板减少性紫癜(ITP)患者的联合化疗(CVP)]
Rinsho Ketsueki. 1998 Mar;39(3):193-7.
9
[Intravenous high-dose methylprednisolone efficacy for treatment of idiopathic thrombocytopenic purpura in adults].静脉注射大剂量甲泼尼龙治疗成人特发性血小板减少性紫癜的疗效
Ned Tijdschr Geneeskd. 1999 Oct 9;143(41):2053-7.
10
Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (TTP): report of three cases.利妥昔单抗治疗难治性特发性血小板减少性紫癜(ITP)和血栓性血小板减少性紫癜(TTP):三例报告
Am J Hematol. 2005 Jan;78(1):49-54. doi: 10.1002/ajh.20243.

引用本文的文献

1
AZD4547 targets the FGFR/Akt/SOX2 axis to overcome paclitaxel resistance in head and neck cancer.AZD4547 靶向 FGFR/Akt/SOX2 轴以克服头颈部癌症对紫杉醇的耐药性。
Cell Oncol (Dordr). 2022 Feb;45(1):41-56. doi: 10.1007/s13402-021-00645-6. Epub 2021 Nov 27.
2
Transcriptomic analysis reveals the oncogenic role of S6K1 in hepatocellular carcinoma.转录组分析揭示了S6K1在肝细胞癌中的致癌作用。
J Cancer. 2020 Feb 19;11(9):2645-2655. doi: 10.7150/jca.40726. eCollection 2020.
3
Silencing growth hormone receptor inhibits estrogen receptor negative breast cancer through ATP-binding cassette sub-family G member 2.
沉默生长激素受体通过 ATP 结合盒亚家族 G 成员 2 抑制雌激素受体阴性乳腺癌。
Exp Mol Med. 2019 Jan 7;51(1):1-13. doi: 10.1038/s12276-018-0197-8.